Best Growth Stocks to Buy for September 15th

Zacks highlighted Valero Energy, Schneider National and Oscar Health as Zacks Rank #1 (Strong Buy) growth candidates. Current-year consensus earnings estimates rose 30.9% for Valero, 14.3% for Schneider National and 227.7% for Oscar Health over the past 60 days. The article is analyst-screening commentary rather than a company-specific operating update, limiting likely market impact.

Analysis

The signal is primarily backward-looking estimate momentum, not new fundamental information; it is unlikely to sustain a broad rerating absent upcoming guidance confirmation. VLO is the most economically sensitive: incremental refining-margin strength can convert rapidly to FCF, but the stock already trades on crack spreads, inventory data and maintenance/outage conditions rather than analyst revisions. A narrowing gasoline/distillate crack or weaker product demand over the next 1-3 months would erase the apparent earnings momentum faster than for the other two names.

SNDR's revisions are more useful if they reflect a genuine turn in contract pricing and utilization rather than lower-cost assumptions. A freight-cycle recovery would disproportionately benefit higher-operating-leverage truckload peers such as KNX and WERN, while intermodal exposure creates a second-order read-through to rail volumes at UNP and NSC; however, excess truck capacity and a soft industrial-production backdrop remain the key constraints through the next two quarters.

OSCR has the highest revision magnitude but also the lowest-quality signal without evidence that medical-loss-ratio performance, risk adjustment and membership retention are improving. Health-insurer multiples compress abruptly when utilization trends turn, and a large percentage estimate change can simply reflect a low prior earnings base. The contrarian view is that the publication itself has negligible incremental informational value: systematic buyers may create a short-lived flow bid, but earnings-call verification—not rank changes—is the actionable catalyst.

Key Decisions for Investors

• No standalone trade on the ranking publication; treat any same-day strength as liquidity-driven unless corroborated by revised company guidance, segment data or independent consensus dispersion.
• Watch VLO versus XLE over the next 1-3 months: initiate a tactical long VLO/short XLE pair only if Gulf Coast crack spreads remain firm and VLO guidance or throughput expectations rise. Exit if benchmark cracks fall more than 15% from entry or gasoline inventory builds persist for two consecutive reports.
• Place SNDR, KNX and WERN on a freight-turn watchlist for the next two earnings cycles. Favor long SNDR/short WERN only after spot rates, contract repricing and SNDR operating ratio each improve; absent those data, the revision signal does not overcome capacity oversupply risk.
• Avoid chasing OSCR on percentage estimate revisions. Reassess after quarterly medical-loss ratio and full-year risk-adjustment commentary; a guidance increase with stable MLR would support a 6-12 month long, while rising utilization or a higher MLR would falsify the thesis.